PAVM
PAVmed Inc.Company Information
- Company Name
- PAVmed Inc.
- CIK
- CIK0001624326
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PAVM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PAVM
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-12-07
- Last sale
- 2020-11-25
- Shares purchased (TTM)
- 100,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 935,867
- Shares outstanding
- 6,269,384
- Ownership
- 14.93%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 11.39%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | - | - | - | 3 | 4 | 3 | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | - | - | - | - | - | - | - | 0 | 1 | 0 | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 5 | 7 | 3 | 4 | 5 | 4 | 2 | 2 | 30 | 30 | 24 | 32 | ||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 6 | 2 | - | - | - | 1 | 1 | 25 | 26 | 20 | 26 | ||||||
Assets | ||||||||||||||||||
| Receivables Net Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | - | - | - | 1 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | ||||||
| Prepaid Expense And Other Assets Current | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 4 | 5 | 6 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 6 | 4 | 4 | 5 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 2 | ||||||
| Equity Method Investments | 33 | 36 | 34 | 32 | 36 | 47 | 26 | 26 | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Assets | 40 | 45 | 39 | 38 | 44 | 53 | 31 | 31 | 39 | 37 | 33 | 42 | ||||||
| Accounts Payable Current | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 2 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 3 | 3 | 2 | 5 | 5 | 7 | 7 | 7 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 15 | 10 | 11 | 10 | 35 | 38 | 53 | 55 | 54 | 55 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 2 | ||||||
| Secured Debt Current | 0 | 0 | 11 | 7 | 7 | 7 | 29 | 32 | 44 | 46 | 44 | 45 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Secured Long Term Debt | 15 | 15 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 3 | 3 | 3 | ||||||
| Liabilities | 21 | 20 | 17 | 12 | 12 | 12 | 38 | 40 | 58 | 58 | 57 | 58 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | 3 | 3 | 2 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Additional Paid In Capital | 296 | 295 | 268 | 265 | 264 | 256 | 249 | 248 | 244 | 238 | 238 | 232 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 35 | 40 | 22 | 23 | 28 | 39 | -7 | -5 | -19 | -69 | -54 | -16 | ||||||
| Retained Earnings Accumulated Deficit | -265 | -259 | -259 | -257 | -251 | -237 | -255 | -256 | -321 | -310 | -294 | -279 | ||||||
| Minority Interest | -16 | -15 | -12 | -10 | -9 | -6 | -5 | -5 | 55 | 48 | 30 | 27 | ||||||
| Liabilities And Stockholders Equity | 40 | 45 | 39 | 38 | 44 | 53 | 31 | 31 | 39 | 37 | 33 | 42 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | - | - | - | 20 | 20 | 20 | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 25 | 25 | 25 | 250 | 250 | 250 | 25 | 50 | 50 | 50 | 250 | 250 | ||||||
| Common Stock Shares Issued | 6 | 6 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Shares Outstanding | 6 | 6 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPAVmed Inc. (PAVM) — SEC Financial Statements & Analysis
PAVmed Inc. (PAVM) is a surgical & medical instruments & apparatus company, incorporated in DE. PAVmed Inc. trades on Nasdaq as: PAVM. PAVmed Inc. (PAVM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, PAVmed Inc. carries a market cap of $37.24M, a P/E ratio of -1.64x, a P/B ratio of 1.93x, a P/S ratio of 332.50x, an enterprise value of $48.56M, and an EV/EBITDA multiple of -1.82x. On profitability, it posts a gross margin of -221.43%, an operating margin of -23841.07%, a net margin of -20318.75%, a Return on Equity (ROE) of -95.89%, a Return on Assets (ROA) of -54.11%, and a Return on Invested Capital (ROIC) of -86.69%. Per share, it reports EPS of $-3.63, diluted EPS of $-3.63, free cash flow per share of $-1.24, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -89.02% year-over-year, net income growth of -129.80% year-over-year, and EPS growth of -102.87% year-over-year. On the balance sheet, it maintains a current ratio of 1.19x, a quick ratio of 0.93x, working capital of $770.00K, a debt-to-equity ratio of 1.08x, a debt ratio of 0.52, an interest coverage ratio of -2054.00x, free cash flow of $-7.78M (TTM), and net debt of $11.32M. Figures sourced from SEC EDGAR.
- Market Cap
- $37.24M
- P/E TTM
- -1.64x
- EPS TTM
- $-3.63
- P/B TTM
- 1.93x
- ROE TTM
- -95.89%
- ROA TTM
- -54.11%
- Debt To Equity
- 1.08x
- Free Cash Flow TTM
- $-7.78M
- Net Revenue TTM Growth 1Y
- -89.02%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PAVmed Inc. in?
PAVmed Inc. (PAVM) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PAVM trade on?
PAVmed Inc. (PAVM) trades on the Nasdaq.
Where is PAVmed Inc. incorporated?
PAVmed Inc. is incorporated in DE.
When was PAVmed Inc. (PAVM)'s most recent SEC filing?
PAVmed Inc. (PAVM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is PAVM's market cap?
PAVmed Inc. (PAVM) has a market capitalization of $37.24M as of 2026-06-30.
What is PAVM's EPS (earnings per share)?
PAVmed Inc. (PAVM)'s trailing twelve month EPS is $-3.63 as of 2026-06-30.
What is PAVM's ROE (return on equity)?
PAVmed Inc. (PAVM)'s trailing twelve month Return on Equity (ROE) is -95.89% as of 2026-06-30.
What is PAVM's ROA (return on assets)?
PAVmed Inc. (PAVM)'s trailing twelve month Return on Assets (ROA) is -54.11% as of 2026-06-30.
What is PAVM's ROIC (return on invested capital)?
PAVmed Inc. (PAVM)'s trailing twelve month Return on Invested Capital (ROIC) is -86.69% as of 2026-06-30.
What is PAVM's EV/EBITDA?
PAVmed Inc. (PAVM)'s trailing twelve month EV/EBITDA is -1.82x as of 2026-06-30.